Mobile

A Multi-center, Randomized, Double-blind, Comparator-controlled, Dose-escalation Safety Assessment Study of Combination Treatment with IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 ...

Update Il y a 4 ans
Reference: EUCTR2009-011099-31

A Multi-center, Randomized, Double-blind, Comparator-controlled, Dose-escalation Safety Assessment Study of Combination Treatment with IMO-2125 and Ribavirin in Naïve Hepatitis C-infected, Genotype 1 Patients

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Assessment of the safety and tolerability of different dosages of IMO-2125 in combination with standard ribavirin compared to placebo and ribavirin or to Pegasys plus ribavirin.

Inclusion criteria

  • Naïve Hepatitis C

Links